Fatty acids bound to human serum albumin and its structural variants modulate apolipoprotein B secretion in HepG2 cells

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1761, Issue 7, 2006, Pages 717-724

  Ha, Ji Sook ^a   Theriault, Andre ^a   Bhagavan, Nadhipuram V ^a   Ha, Chung Eun ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Apolipoprotein B100; Fatty acid; HepG2 cell; Human serum albumin; In vitro protein expression; Site directed mutagenesis

Indexed keywords

APOLIPOPROTEIN B; FATTY ACID; HUMAN SERUM ALBUMIN; LIPOPROTEIN; OLEIC ACID;

ARTICLE; BINDING AFFINITY; CELL STRAIN HEPG2; CONTROLLED STUDY; HUMAN; HUMAN CELL; INCUBATION TIME; LIVER CELL; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; SITE DIRECTED MUTAGENESIS; STATISTICAL SIGNIFICANCE; WILD TYPE;

APOLIPOPROTEINS B; CELL LINE, TUMOR; CORONARY DISEASE; HEPATOCYTES; HUMANS; MUTAGENESIS, SITE-DIRECTED; MUTATION; OLEIC ACID; PROTEIN BINDING; SERUM ALBUMIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33746312598     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2006.05.016     Document Type: Article

References (33)

1. Gillum R.F., and Makuc D.M. Serum albumin, coronary heart disease, and death. Am. Heart J. 123 (1992) 507-513
2. Goldwasser P., and Feldman J. Association of serum albumin and mortality risk. J. Clin. Epidemiol. 50 (1997) 693-703
3. Fried L.P., Kronmal R.A., Newman A.B., Bild D.E., Mittelmark M.B., Polak J.F., Robbins J.A., and Gardin J.M. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA 279 (1998) 585-592
4. Gillum R.F., Ingram D.D., and Makuc D.M. Relation between serum albumin concentration and stroke incidence and death: the NHANES I Epidemiologic follow-up study. Am. J. Epidemiol. 140 (1994) 876-888
5. Corti M.C., Guralnik J.M., Salive M.E., and Sorkin J.D. Serum albumin level and physical disability as predictors of mortality in older persons. JAMA 272 (1994) 1036-1042
6. Curry S., Mandelkow H., Brick P., and Franks N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat. Struct. Biol. 5 (1998) 827-835
7. Bhattacharya A.A., Grune T., and Curry S. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J. Mol. Biol. 303 (2000) 721-732
8. Zhang Y.L., Hernandez-Ono A., Ko C., Yasunaga K., Huang L.S., and Ginsberg H.N. Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles. J. Biol. Chem. 279 (2004) 19362-19374
9. Ginsberg H.N. Insulin resistance and cardiovascular disease. J. Clin. Invest. 106 (2000) 453-458
10. Hirano T., Furukawa S., Kurokawa M., Ebara T., Dixon J.L., and Nagano S. Intracellular apoprotein B degradation is suppressed by decreased albumin concentration in Hep G2 cells. Kidney Int. 47 (1995) 421-431
11. Pullinger C.R., North J.D., Teng B.B., Rifici V.A., Ronhild de Brito A.E., and Scott J. The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J. Lipid Res. 30 (1989) 1065-1077
12. Spector A.A., John K., and Fletcher J.E. Binding of long-chain fatty acids to bovine serum albumin. J. Lipid Res. 10 (1969) 56-67
13. Richieri G.V., Anel A., and Kleinfeld A.M. Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB. Biochemistry 32 (1993) 7574-7580
14. Ha J.S., Ha C.E., Chao J.T., Petersen C.E., Theriault A., and Bhagavan N.V. Human serum albumin and its structural variants mediate cholesterol efflux from cultured endothelial cells. Biochim. Biophys. Acta 1640 (2003) 119-128
15. Huang B.X., Kim H.Y., and Dass C. Probing three-dimensional structure of bovine serum albumin by chemical cross-linking and mass spectrometry. J. Am. Soc. Mass Spectrom. 15 (2004) 1237-1247
16. Simard J.R., Zunszain P.A., Ha C.E., Yang J.S., Bhagavan N.V., Petitpas I., Curry S., and Hamilton J.A. Locating high-affinity fatty acid-binding sites on albumin by X-ray crystallography and NMR spectroscopy. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 17958-17963
17. Carter D.C., and Ho J.X. Structure of serum albumin. Adv. Protein Chem. 45 (1994) 153-203
18. Macri J., and Adeli K. Development of an amplified enzyme-linked immunosorbent assay for sensitive measurement of apolipoprotein B in plasma and tissue culture media. Eur. J. Clin. Chem. Clin. Biochem. 31 (1993) 441-446
19. Theriault A., Wang Q., Gapor A., and Adeli K. Effects of gamma-tocotrienol on ApoB synthesis, degradation, and secretion in HepG2 cells. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 704-712
20. Ha C.E., Petersen C.E., Park D., Harohalli K., and Bhagavan N.V. Identification of key amino acid residues involved in specific interactions between digoxin and human serum albumin. J. Biochem. Mol. Biol. Biophys. 2 (1999) 201-207
21. Petitpas I., Grune T., Bhattacharya A.A., and Curry S. Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J. Mol. Biol. 314 (2001) 955-960
22. Sparks J.D., and Sparks C.E. Apolipoprotein B and lipoprotein metabolism. Adv. Lipid Res. 21 (1985) 1-46
23. Sharrett A.R., Ballantyne C.M., Coady S.A., Heiss G., Sorlie P.D., Catellier D., and Patsch W. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) study. Circulation 104 (2001) 1108-1113
24. Walldius G., Jungner I., Holme I., Aastveit A.H., Kolar W., and Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358 (2001) 2026-2033
25. Fielding C.J., Havel R.J., Todd K.M., Yeo K.E., Schloetter M.C., Weinberg V., and Frost P.H. Effects of dietary cholesterol and fat saturation on plasma lipoproteins in an ethnically diverse population of healthy young men. J. Clin. Invest. 95 (1995) 611-618
26. Julius U. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia. Exp. Clin. Endocrinol. Diabetes 111 (2003) 246-250
27. Dashti N., Feng Q., and Franklin F.A. Long-term effects of cis and trans monounsaturated (18:1) and saturated (16:0) fatty acids on the synthesis and secretion of apolipoprotein A-I- and apolipoprotein B-containing lipoproteins in HepG2 cells. J. Lipid Res. 41 (2000) 1980-1990
28. Wang H., Chen X., and Fisher E.A. N-3 fatty acids stimulate intracellular degradation of apoprotein B in rat hepatocytes. J. Clin. Invest. 91 (1993) 1380-1389
29. Arrol S., Mackness M.I., and Durrington P.N. The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2). Atherosclerosis 150 (2000) 255-264
30. Fisher E.A., and Ginsberg H.N. Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins. J. Biol. Chem. 277 (2002) 17377-17380
31. Fisher E.A., Pan M., Chen X., Wu X., Wang H., Jamil H., Sparks J.D., and Williams K.J. The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways. J. Biol. Chem. 276 (2001) 27855-27863
32. Sakata N., and Dixon J.L. Ubiquitin-proteasome-dependent degradation of apolipoprotein B100 in vitro. Biochim. Biophys. Acta 1437 (1999) 71-79
33. Dixon J.L., Furukawa S., and Ginsberg H.N. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J. Biol. Chem. 266 (1991) 5080-5086